Aerovate Therapeutics

0 followers

‌

Aerovate is a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease.

Industries

Biotechnology

Headquarters

Boston, United States

Employees

11-50

Links

Org chart

Tim Noyes

CEO

Tim Noyes

Collapse

Hunter Gillies

Chief Medical Officer

George Eldridge

Chief Financial Officer

Sue Fischer

SVP, Development Operations

Stephen Yu

SVP, Quality

Sanjeev Khindri

SVP, Clinical Development

Cheryl Lassen

SVP, Clinical Development

Sean Plunkett

Vice President, Manufacturing And Device Engineering

Kevin Kee

VP Of Pharmaceutical Development

Donna Dea

Head of Regulatory

Laetitia Baudet-Mpoutou

Director Of Diversity, Equity, Inclusion And Belonging

Teams

Directors Team

8 members

Pharmaceutical Development and Operations

5 members

Leadership Team

3 members

Medical and Clinical Development

4 members

Similar companies

Synthekine

3 followers

Tessera Therapeutics

2 followers

Vaxcyte

2 followers

Neogene Therapeutics

2 followers

Apogee Therapeutics

1 follower

PMV Pharmaceuticals

1 follower

Slingshot Biosciences

1 follower

HydroPeptide LLC

3 followers

Priovant

2 followers

Gilead Sciences

129 followers

Biogen

115 followers

Explore companies